-
Zaiding Medicine: Clinical study of KarXT for the treatment of schizophrenia completed, enrolled patients from mainland China
On August 13th, Zaiding Pharmaceutical announced that the UNITE-1 study of KarXT (Xanomeline Tropium) for schizophrenia has completed the enrollment of all mainland Chinese patients. Zaiding Pharmace ... -
AstraZeneca: Clinical studies have shown that targeted anti-cancer drug Teresa can prolong progression free survival by more than 3 years
On June 2nd local time, AstraZeneca announced that positive results from the LAURA Phase III trial showed that Teresa (ositinib) showed statistically significant and highly clinically significant imp ... -
Longest Clinical Study of Smegglutide Published: Continuous Four Years of Medication Can Maintain 10% Weight Loss
[The longest clinical study of Smeglutide was published: it can maintain a weight loss of 10% after four years of medication] Star weight loss therapy Smeglutide manufacturer Novo Nordisk displayed t ...